Skip to main content

Table 3 Device compression and compression rate in patients with peri-device leakage

From: Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device

  post-Implantation at six weeks at six months
  No Yes p No Yes p No Yes p
DCmax 1.30 ± 0.14 1.27 ± 0.10 0.21 1,29 ± 0.15 1.30 ± 0.11 0.65 1.29 ± 0.15 1.29 ± 0.10 0.93
DCmin 1.20 ± 0.12 1.20 ± 0.10 0.91 1.19 ± 0.12 1.21 ± 0.11 0.50 1.20 ± 0.13 1.20 ± 0.11 0.93
CRmax 1.50 ± 0.22 1.40 ± 0.18 0.02 1.49 ± 0.23 1.41 ± 0.18 0.12 1.49 ± 0.23 1.41 ± 0.15 0.10
CRmin 1.24 ± 0.18 1.18 ± 0.15 0.07 1.24 ± 0.20 1.20 ± 0.13 0.26 1.23 ± 0.18 1.22 ± 0.15 0.29
  1. DCmax = (nominal device size / minimal device diameter), DCmin = (nominal device size / maximal device diameter) CRmax = (nominal device size / minimal LAA ostium diameter), CRmin = (nominal device size / maximal LAA ostium diameter)